These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 4613464)

  • 21. Clinical applications of the pharmacokinetics of lidocaine.
    Benowitz NL
    Cardiovasc Clin; 1974; 6(2):77-101. PubMed ID: 4613465
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacologic and clinical control of antiarrhythmic drugs.
    Bigger JT
    Am J Med; 1975 Apr; 58(4):479-88. PubMed ID: 1092163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pharmacokinetics of digitoxin.
    Perrier D; Mayersohn M; Marcus FI
    Clin Pharmacokinet; 1977; 2(4):292-311. PubMed ID: 902449
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of plasma levels in evaluation of procainamide dosage.
    Shaw TR; Kumana CR; Royds RB; Padgham CM; Hamer J
    Br Heart J; 1974 Mar; 36(3):265-70. PubMed ID: 4132893
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia].
    Bracchetti D; Mantovani B; Naccarella F; Lombardi G; Palmieri M
    Boll Soc Ital Cardiol; 1980; Suppl():117-23. PubMed ID: 7349604
    [No Abstract]   [Full Text] [Related]  

  • 26. [Serum concentrations of procainamide during treatment with ordinary and sustained-release tablets].
    Henningsen P; Laursen HB; Christiansen BD; Moller J
    Ugeskr Laeger; 1976 Sep; 138(40):2433-7. PubMed ID: 968997
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical pharmacology of procainamide and its active metabolite -N-acetylprocainamide].
    Matusewicz W; Orszulak DE
    Przegl Lek; 1984; 41(5):379-83. PubMed ID: 6206523
    [No Abstract]   [Full Text] [Related]  

  • 28. [Value of blood tests in procaine amide use (apropos of 188 tests in 36 patients)].
    Chiche P; Benaim R; Lellouch A; Godard JP
    Arch Mal Coeur Vaiss; 1972 Jul; 65(7):797-803. PubMed ID: 4633517
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical pharmacokinetics of some antiarrhythmic drugs.
    Ochs HR; Greenblatt DJ; Bodem G
    Herz; 1979 Aug; 4(4):330-43. PubMed ID: 391683
    [No Abstract]   [Full Text] [Related]  

  • 30. [Lidocaine pharmacokinetics when administered intramuscularly].
    Piotrovskiĭ VK; Smirnova EB; Riabokon' OS; Metelitsa VI
    Farmakol Toksikol; 1980; 43(4):411-6. PubMed ID: 7439378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Procainamide acetylation and disposition in dialysis patients.
    Nattel S; Ogilvie RI; Kreeft J; Sitar DS; Graham DN; Rangno RE; Dufresne LR; Barre PE
    Clin Invest Med; 1979; 2(1):5-11. PubMed ID: 509808
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical pharmacokinetics of verapamil and nifedipine].
    Rumiantsev DO; Piotrovskiĭ VK; Metelitsa VI
    Farmakol Toksikol; 1985; 48(1):99-109. PubMed ID: 3884367
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term use of procaine amide following acute myocardial infarction.
    Kosowsky BD; Taylor J; Lown B; Ritchie RF
    Circulation; 1973 Jun; 47(6):1204-10. PubMed ID: 4122729
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical pharmacology of anti-arrhythmia agents. I. Quinidine, procainamide and disopyramide].
    Witkowska M
    Kardiol Pol; 1981; 24(7):505-17. PubMed ID: 7024612
    [No Abstract]   [Full Text] [Related]  

  • 35. [Modification by lidocain and other anti-arrhythmia agents on the combination of fixed and variably coupled ectopic ventricular beats].
    Burkhardt D; Steinbrunn W; Kaufmann G
    Schweiz Med Wochenschr; 1973 Dec; 103(50):1787-9. PubMed ID: 4768697
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasma concentration of procainamide and prevalence of exertional arrhythmias.
    Gey GO; Levy RH; Fisher L; Pettet G; Bruce RA
    Ann Intern Med; 1974 Jun; 80(6):718-22. PubMed ID: 4832159
    [No Abstract]   [Full Text] [Related]  

  • 37. Salicylate pharmacokintics in the dog.
    McCann WP; Palmisano PA
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):17-25. PubMed ID: 4686099
    [No Abstract]   [Full Text] [Related]  

  • 38. The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans.
    Aitio ML; Allonen H; Kanto J; Mäntylä R
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):219-26. PubMed ID: 7095921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Isotope technics in studies on dilazep pharmacokinetics and metabolism in the rat].
    Schaumlöffel E; Clausnitzer M
    Arzneimittelforschung; 1972 Oct; 22(10):1643-50. PubMed ID: 4677051
    [No Abstract]   [Full Text] [Related]  

  • 40. Basic pharmacokinetics.
    Levy RH; Bauer LA
    Ther Drug Monit; 1986; 8(1):47-58. PubMed ID: 3515640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.